Dataset Information


TREM-2 promotes macrophage survival and lung disease after respiratory viral infection.

ABSTRACT: Viral infections and type 2 immune responses are thought to be critical for the development of chronic respiratory disease, but the link between these events needs to be better defined. Here, we study a mouse model in which infection with a mouse parainfluenza virus known as Sendai virus (SeV) leads to long-term activation of innate immune cells that drive IL-13-dependent lung disease. We find that chronic postviral disease (signified by formation of excess airway mucus and accumulation of M2-differentiating lung macrophages) requires macrophage expression of triggering receptor expressed on myeloid cells-2 (TREM-2). Analysis of mechanism shows that viral replication increases lung macrophage levels of intracellular and cell surface TREM-2, and this action prevents macrophage apoptosis that would otherwise occur during the acute illness (5-12 d after inoculation). However, the largest increases in TREM-2 levels are found as the soluble form (sTREM-2) long after clearance of infection (49 d after inoculation). At this time, IL-13 and the adapter protein DAP12 promote TREM-2 cleavage to sTREM-2 that is unexpectedly active in preventing macrophage apoptosis. The results thereby define an unprecedented mechanism for a feed-forward expansion of lung macrophages (with IL-13 production and consequent M2 differentiation) that further explains how acute infection leads to chronic inflammatory disease.


PROVIDER: S-EPMC4419356 | BioStudies | 2015-01-01

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7590420 | BioStudies
2018-01-01 | S-EPMC5974358 | BioStudies
2018-01-01 | S-EPMC5812763 | BioStudies
2018-01-01 | S-EPMC6050254 | BioStudies
1000-01-01 | S-EPMC4188746 | BioStudies
2016-01-01 | S-EPMC5130024 | BioStudies
2004-01-01 | S-EPMC2211948 | BioStudies
2015-01-01 | S-EPMC4612298 | BioStudies
2019-01-01 | S-EPMC6738594 | BioStudies
2013-01-01 | S-EPMC3754239 | BioStudies